Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11932688 Treatment for neoplastic diseases

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 20, 2018
0
Date of Patent
March 19, 2024
0
Patent Applicant
Janssen Biotech
Janssen Biotech
0
Patent Application Number
16228060
0
Patent Citations
‌
US Patent 8242074 Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
0
‌
US Patent 8388956 Interleukin-1 alpha antibodies and methods of use
0
‌
US Patent 8388969 Interleukin-1 alpha antibodies and methods of use
0
‌
US Patent 8398966 IL-1 binding proteins
0
‌
US Patent 8546331 Modulation of pathogenic CD14+/CD16+ monocytes
0
‌
US Patent 8679489 Inhibiting cell migration
0
‌
US Patent 8697689 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
0
‌
US Patent 8784817 Method for killing IL-1 alpha expressing cells
0
‌
US Patent 9181338 Human antibody specific for IL-1alpha
0
‌
US Patent 9416172 Compositions and methods for treating and preventing
0
•••
Patent Inventor Names
John Simard
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11932688
0
Patent Primary Examiner
‌
Michael D Pak
0

Find more entities like US Patent 11932688 Treatment for neoplastic diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo